• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞治疗肌肉萎缩症——我们进展如何?

Stem cells to treat muscular dystrophies - where are we?

机构信息

The Dubowitz Neuromuscular Centre, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom.

出版信息

Neuromuscul Disord. 2011 Jan;21(1):4-12. doi: 10.1016/j.nmd.2010.10.004. Epub 2010 Nov 4.

DOI:10.1016/j.nmd.2010.10.004
PMID:21055938
Abstract

The muscular dystrophies are inherited disorders characterised by progressive muscle wasting and weakness. Stem cell therapy is considered to be one of the most promising strategies for treating muscular dystrophies. In this review, we first examine the evidence that a stem cell could be used to treat muscular dystrophies, and then discuss the criteria that an ideal stem cell should meet. We also highlight the importance of standard operation procedures to be followed for ensuring the consistent and reproducible efficacy of a particular stem cell. While at the moment the scientific community is looking for an ideal stem cell to treat muscular dystrophies, it is clear that in order for this field to benefit from therapeutic stem cell applications, additional careful investigations are required.

摘要

肌肉萎缩症是一种遗传性疾病,其特征是肌肉逐渐萎缩和无力。干细胞疗法被认为是治疗肌肉萎缩症最有前途的策略之一。在这篇综述中,我们首先检查了使用干细胞治疗肌肉萎缩症的证据,然后讨论了理想的干细胞应满足的标准。我们还强调了为确保特定干细胞的一致和可重复的疗效而应遵循的标准操作程序的重要性。虽然目前科学界正在寻找一种理想的干细胞来治疗肌肉萎缩症,但显然,为了使该领域受益于治疗性干细胞应用,还需要进行更多的仔细研究。

相似文献

1
Stem cells to treat muscular dystrophies - where are we?干细胞治疗肌肉萎缩症——我们进展如何?
Neuromuscul Disord. 2011 Jan;21(1):4-12. doi: 10.1016/j.nmd.2010.10.004. Epub 2010 Nov 4.
2
Stem cells to treat muscular dystrophies.用于治疗肌肉萎缩症的干细胞。
Acta Myol. 2005 Dec;24(3):181-3.
3
Stem cell therapy for muscular dystrophy.
Expert Opin Biol Ther. 2004 Jan;4(1):1-9. doi: 10.1517/14712598.4.1.1.
4
Stem cell therapies to treat muscular dystrophy: progress to date.干细胞疗法治疗肌肉萎缩症:迄今为止的进展。
BioDrugs. 2010 Aug 1;24(4):237-47. doi: 10.2165/11534300-000000000-00000.
5
The potential of stem cells in orthopaedic surgery.干细胞在骨科手术中的潜力。
J Bone Joint Surg Br. 2006 Jul;88(7):841-51. doi: 10.1302/0301-620X.88B7.17305.
6
Stem cell based therapies to treat muscular dystrophy.基于干细胞的疗法治疗肌肉萎缩症。
Biochim Biophys Acta. 2007 Feb;1772(2):272-83. doi: 10.1016/j.bbadis.2006.08.011. Epub 2006 Sep 6.
7
Muscular dystrophies and stem cells: a therapeutic challenge.
Cytotherapy. 2002;4(6):513-9. doi: 10.1080/146532402761624665.
8
A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies-In Vitro and In Vivo Treatments to Boost Cellular Engraftment.基于干细胞的肌肉萎缩症疗法的广阔前景——体外和体内治疗以促进细胞移植。
Int J Mol Sci. 2019 Oct 31;20(21):5433. doi: 10.3390/ijms20215433.
9
Combining stem cells and exon skipping strategy to treat muscular dystrophy.结合干细胞与外显子跳跃策略治疗肌肉萎缩症。
Expert Opin Biol Ther. 2008 Aug;8(8):1051-61. doi: 10.1517/14712598.8.8.1051.
10
Treating muscular dystrophy with stem cells?
Cell. 2006 Dec 29;127(7):1304-6. doi: 10.1016/j.cell.2006.12.010.

引用本文的文献

1
Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.人源抗肌萎缩蛋白嵌合(DEC)细胞疗法改善杜氏肌营养不良症的心脏、呼吸和骨骼肌功能。
Stem Cells Transl Med. 2021 Oct;10(10):1406-1418. doi: 10.1002/sctm.21-0054. Epub 2021 Jul 22.
2
Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.骨髓间充质干细胞和成年供体的肌源性干细胞/祖细胞的共移植可改善杜氏肌营养不良症患者的肌肉功能。
Cells. 2020 Apr 30;9(5):1119. doi: 10.3390/cells9051119.
3
Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues.
源自各种人体组织的间充质干/祖细胞之间的异同。
World J Stem Cells. 2019 Jun 26;11(6):347-374. doi: 10.4252/wjsc.v11.i6.347.
4
Current Methods for Skeletal Muscle Tissue Repair and Regeneration.骨骼肌组织修复与再生的当前方法。
Biomed Res Int. 2018 Apr 16;2018:1984879. doi: 10.1155/2018/1984879. eCollection 2018.
5
Cellular Therapy for Chronic Traumatic Brachial Plexus Injury.慢性创伤性臂丛神经损伤的细胞治疗
Adv Biomed Res. 2018 Mar 27;7:51. doi: 10.4103/2277-9175.228631. eCollection 2018.
6
Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.肌肉干细胞/祖细胞和骨髓来源的间充质干细胞在肌肉疾病中的骨骼肌再生。
Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354. doi: 10.1007/s00005-018-0509-7. Epub 2018 Mar 13.
7
Programming gene and engineered-cell therapies with synthetic biology.利用合成生物学进行基因编程和工程细胞治疗。
Science. 2018 Feb 9;359(6376). doi: 10.1126/science.aad1067.
8
Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy.针对肌肉干细胞内在缺陷治疗杜氏肌营养不良症。
NPJ Regen Med. 2016;1:16006-. doi: 10.1038/npjregenmed.2016.6. Epub 2016 Jun 9.
9
Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.芯片上的骨骼肌分化显示人供体中血管周细胞在杜兴氏肌营养不良模型中恢复抗肌萎缩蛋白的效率。
Stem Cells Transl Med. 2016 Dec;5(12):1676-1683. doi: 10.5966/sctm.2015-0053. Epub 2016 Aug 8.
10
Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A.中胚层血管母细胞递送微小聚集蛋白改善1A型缺乏层黏连蛋白的先天性肌营养不良小鼠模型。
Skelet Muscle. 2015 Sep 3;5:30. doi: 10.1186/s13395-015-0055-5. eCollection 2015.